The Patent Finder

Pacira Therapeutics, Inc.

Also on record
Records under this name other than the patents Pacira Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.

Showing 1 to 3 of 3 · Back to Pacira Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,480,677Enantiomers of Spiro-Oxindole Compounds and Their Uses as Therapeutic Agents
Lapsed on the fee record
Ended Nov 1, 2024 · Low confidence
Lapsed on the fee recordEnded Nov 1, 2024Low confidence
US 9,260,446Synthetic Methods for Spiro-Oxindole Compounds
Lapsed on the fee record
Ended Feb 16, 2024 · Medium confidence
Lapsed on the fee recordEnded Feb 16, 2024Medium confidence
US 10,513,526Solid State Forms of Spiro-Oxindole Compounds
Lapsed on the fee record
Ended Dec 24, 2023 · High confidence
Lapsed on the fee recordEnded Dec 24, 2023High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited